SCHEMBL6628865

SCHEMBL6628865

CCc1ccncc1-c1nc(-c2ccc(O)cc2)cs1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 7/20 0.58
SREBF2 Q12772 1/20 0.51
KDM4E B2RXH2 4/20 0.49
MAPT P10636 4/20 0.49
POLB P06746 2/20 0.49
ATM Q13315 1/20 0.49
RAB9A P51151 5/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
NPC1 O15118 3/20 0.47
CYP1A1 P04798 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2E1 P05181 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C8 P10632 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2A6 P11509 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP4B1 P13584 1/20 0.46
CYP2B6 P20813 1/20 0.46
CYP3A5 P20815 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6649374 0.91 SREBF2 (0.59) CYP19A1SREBF2KDM4EMAPTPOLB
SCHEMBL6628863 0.88 CYP19A1 (0.48) CYP19A1SREBF2KDM4ERAB9ASMN1; SMN2
SCHEMBL6646406 0.87 KDM4E (0.61) CYP19A1SREBF2KDM4EMAPTATM
SCHEMBL6649987 0.87 KDM4E (0.56) CYP19A1SREBF2KDM4ERAB9ANPC1
SCHEMBL6652389 0.86 KDM4E (0.59) CYP19A1SREBF2KDM4ERAB9ANPC1
SCHEMBL6626251 0.84 KDM4E (0.52) CYP19A1KDM4ERAB9ASMN1; SMN2NPC1
SCHEMBL6651298 0.82 CYP19A1 (0.47) CYP19A1KDM4ERAB9ASMN1; SMN2NPC1
SCHEMBL6646510 0.81 CDC25A (0.56) CYP19A1KDM4EMAPTRAB9ASMN1; SMN2
SCHEMBL6648675 0.81 EIF4E (0.58) KDM4ERAB9ANPC1MEN1KMT2A
SCHEMBL6649359 0.81 CYP19A1 (0.46) CYP19A1KDM4EMAPTRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432706-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS Bayer Pharmaceuticals Corporation (US) 2004-06-30 EP disclosed
WO-2003027085-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed